{"id":2409,"date":"2026-06-26T18:17:00","date_gmt":"2026-06-26T18:17:00","guid":{"rendered":"https:\/\/admarebio.com\/news-events\/news-insights\/"},"modified":"2026-07-14T18:26:13","modified_gmt":"2026-07-14T18:26:13","slug":"the-future-of-bioinnovation-what-canada-must-do-now-to-lead","status":"publish","type":"post","link":"https:\/\/admarebio.com\/news-events\/news-insights\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\/","title":{"rendered":"The Future of BioInnovation: What Canada Must Do Now to Lead"},"content":{"rendered":"\n

Originally published: https:\/\/thefutureeconomy.ca\/op-eds\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\/<\/em><\/p>\n\n\n\n

Canada is making a series of deliberate choices about its economic and strategic future. We are diversifying trading partners, investing in domestic capacity and strengthening our commitment to national defence and security.<\/p>\n\n\n\n

In bioinnovation, the equivalent choice is whether Canada will simply be a discovery engine or whether it will build and own globally competitive companies from that discovery.\u00a0<\/p>\n\n\n\n

The hard truth is that right now, too much of the economic and strategic value generated by Canada\u2019s innovation ecosystem leaves the country. We fund world-class discovery through universities, hospitals and public research programs, then watch the resulting intellectual property, talent and commercial upside migrate elsewhere once commercialization begins.\u00a0<\/p>\n\n\n\n

This is not a new observation, but it is an increasingly urgent one.<\/p>\n\n\n\n

Why Bioinnovation Is Critical to Canada\u2019s Future<\/strong><\/p>\n\n\n\n

Bioinnovation\u00a0sits\u00a0at the intersection of Canada\u2019s most pressing priorities: health security, economic resilience and national defence. It is a sector where the ability to translate discovery into domestic capability matters \u2013 not just for growth, but for sovereignty.\u00a0<\/p>\n\n\n\n

If Canada wants to lead, it must make a deliberate national choice: to build a system that consistently turns world-class science into globally competitive Canadian companies.  <\/p>\n\n\n\n

Where Canadian Bioinnovation Is Today<\/strong><\/p>\n\n\n\n

The problem is not at the beginning of the pipeline. Canada\u2019s scientific research output punches above its weight. And increasingly, it is not at the end either.<\/p>\n\n\n\n

Canada is making important progress in filling domestic gaps to support later-stage growth through initiatives such as the strengthened Venture Capital Catalyst Initiative, BDC\u2019s dedicated life sciences venture fund, the recently announced Canada Strong Fund, and Buy Canada procurement initiatives.\u00a0<\/p>\n\n\n\n

These are important and necessary tools. A longstanding reliance on foreign capital at these stages has meant exporting too much of the value and returns these companies generate. But even the most sophisticated funding mechanisms can only invest in what exists.<\/p>\n\n\n\n

That is the core issue.<\/p>\n\n\n\n

Canada\u2019s Structural Gap: Strong Science, Weak Company Creation<\/strong><\/p>\n\n\n\n

The most critical gap in Canada\u2019s bioinnovation system sits between discovery and scale-up. It is often described as the \u201cmissing middle\u201d, but in practice, it is a\u00a0company creation<\/a>gap.<\/p>\n\n\n\n

Turning a scientific asset into an investable company requires more than capital. It demands purpose-built company formation that integrates experienced leadership, commercial R&D capacity, IP strategy, clinical and regulatory planning and market discipline from the outset. This work happens early, when risk is highest and private investment is least available, but is essential to bridge the gap between research and scale.\u00a0\u00a0<\/p>\n\n\n\n

Without it, there is nothing to grow.<\/p>\n\n\n\n

Bioinnovation’s Role in Economic and National Security<\/strong><\/p>\n\n\n\n

This is not just an economic issue. It is a strategic one.<\/p>\n\n\n\n

Countries around the world are treating biotechnology as core infrastructure. It underpins health security, economic resilience, advanced manufacturing, national defence, and global competitiveness.<\/p>\n\n\n\n

Life sciences are inherently dual-use. The same platforms that support military readiness also strengthen civilian health systems and pandemic preparedness. Investments in biomanufacturing, advanced therapeutics, diagnostics, and data-driven health technologies deliver returns across defence, healthcare, and exports.<\/p>\n\n\n\n

Lessons from Global Bioinnovation Leaders<\/strong><\/p>\n\n\n\n

Other countries are not only funding science that supports national and health security objectives. They are building systems that turn science into companies \u2013 and companies into global leaders.<\/p>\n\n\n\n

The United States offers a clear example. Early-stage, mission-driven investment \u2013 through agencies such as DARPA \u2013 helped support technologies that would later underpin companies like Moderna. This is not just about funding research; it is about building pathways from research to company creation, aligned with national priorities.\u00a0<\/p>\n\n\n\n

Canada\u2019s own Defence Industrial Strategy identifies medical countermeasures as a sovereign capability. That recognition creates an opportunity to align research, commercialization and industrial development in a way that strengthens both national security and economic growth. <\/p>\n\n\n\n

What Canada Must Do Now<\/strong><\/p>\n\n\n\n

There is no single solution, but four actions would materially strengthen our position:\u00a0<\/p>\n\n\n\n

1.\u00a0Make company creation a national priority<\/strong><\/p>\n\n\n\n

Canada\u2019s innovation system is still built around funding research and scaling companies. It must explicitly support the stage in between by investing in organizations and platforms that combine capital, expertise and operational support to turn science into investable companies.\u00a0<\/p>\n\n\n\n

Over the past decade, Canada\u2019s life sciences sector has grown significantly and has been one of the strongest-performing areas for venture investment. We don\u2019t need to invent a new model. We need to scale what is already working.\u00a0<\/p>\n\n\n\n

2.\u00a0Better align early-stage and growth capital<\/strong><\/p>\n\n\n\n

Recent initiatives are critical for mobilizing later-stage capital. But early-stage company creation remains disconnected from many downstream funding pools.\u00a0<\/p>\n\n\n\n

Institutional investors are not in the business of incubating emerging companies. They need investable opportunities with clear governance, milestones and demonstrated global potential.<\/p>\n\n\n\n

Better coordination would help companies built in Canada move more efficiently from formation to scale \u2013 and remain anchored here as they grow.\u00a0<\/p>\n\n\n\n

3.\u00a0Align with Canada\u2019s defence priorities<\/strong><\/p>\n\n\n\n

Canada\u2019s Defence Industrial Strategy\u00a0creates a powerful, mission-oriented framework and a moment of extraordinary opportunity for life sciences.<\/p>\n\n\n\n

We must seize this opportunity to double down on the research-to-commercialization pathways that strengthen public health preparedness, support the Canadian Armed Forces, and build globally competitive life sciences companies.\u00a0<\/p>\n\n\n\n

Leveraging Canadian research strengths in this way advances defence readiness while anchoring industrial growth at home<\/p>\n\n\n\n

4.\u00a0Invest in talent that builds companies<\/strong><\/p>\n\n\n\n

Canada has deep scientific talent, but company building requires a different skill set.\u00a0<\/p>\n\n\n\n

Experienced operators \u2013 leaders who have built and scaled companies \u2013 are critical to success.\u00a0<\/p>\n\n\n\n

We need to do more to attract, develop and retain this talent in Canada.\u00a0<\/p>\n\n\n\n

Without it, even strong ideas will struggle to become successful companies.<\/p>\n\n\n\n

From Investment to Long-Term Impact<\/strong><\/p>\n\n\n\n

Canada does not lack ambition. What we lack is cohesion.<\/p>\n\n\n\n

Important pieces are now in place: strong research, growing pools of capital and a renewed focus on domestic procurement and strategic sectors. The remaining gap is ensuring these elements are connected by a system that consistently produces companies capable of absorbing that capital and delivering on those national priorities.\u00a0\u00a0<\/p>\n\n\n\n

A deliberate focus on company creation is a critical part of completing that system.\u00a0<\/p>\n\n\n\n

Canada\u2019s life sciences future will be determined not only by what we discover, but by what we can build, scale and own.<\/p>\n\n\n\n

The opportunity is clear. It\u2019s time to connect the pieces. <\/p>\n\n\n\n

—<\/p>\n\n\n\n

Matthew Carlyle<\/strong> is President and CEO of adMare BioInnovations<\/strong>, Canada\u2019s life sciences company creation engine. A nine-year leader at adMare, he previously served as COO and CFO. He brings extensive biotech and venture capital experience, having raised and deployed over $500M and helped build and finance numerous life sciences companies.<\/p>\n\n\n\n

adMare BioInnovations<\/strong> is a Canadian organization focused on building and scaling high-potential life sciences companies. The organization provides capital, infrastructure, and talent development to advance innovative health and biotechnology ventures from discovery to commercialization.<\/p>\n","protected":false},"excerpt":{"rendered":"

Originally published: https:\/\/thefutureeconomy.ca\/op-eds\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\/ Canada is making a series of deliberate choices about its economic and strategic future. We are diversifying trading partners, investing in domestic capacity and strengthening our commitment […]<\/p>\n","protected":false},"author":4,"featured_media":2413,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86],"tags":[],"company":[],"class_list":["post-2409","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-admare-insights"],"yoast_head":"\nThe Future of BioInnovation: What Canada Must Do Now to Lead | adMare<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Future of BioInnovation: What Canada Must Do Now to Lead | adMare\" \/>\n<meta property=\"og:description\" content=\"Originally published: https:\/\/thefutureeconomy.ca\/op-eds\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\/ Canada is making a series of deliberate choices about its economic and strategic future. We are diversifying trading partners, investing in domestic capacity and strengthening our commitment […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/admarebio.com\/news-events\/news-insights\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\/\" \/>\n<meta property=\"og:site_name\" content=\"adMare\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-26T18:17:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-14T18:26:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-07-14-at-11.25.48-AM.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1498\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Earnscliffe Strategies\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Earnscliffe Strategies\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\\\/\"},\"author\":{\"name\":\"Earnscliffe Strategies\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#\\\/schema\\\/person\\\/bd78e975574bdbf66541602c00a312da\"},\"headline\":\"The Future of BioInnovation: What Canada Must Do Now to Lead\",\"datePublished\":\"2026-06-26T18:17:00+00:00\",\"dateModified\":\"2026-07-14T18:26:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\\\/\"},\"wordCount\":1143,\"publisher\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Screenshot-2026-07-14-at-11.25.48-AM.png\",\"articleSection\":[\"adMare Insights\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\\\/\",\"url\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\\\/\",\"name\":\"The Future of BioInnovation: What Canada Must Do Now to Lead | adMare\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Screenshot-2026-07-14-at-11.25.48-AM.png\",\"datePublished\":\"2026-06-26T18:17:00+00:00\",\"dateModified\":\"2026-07-14T18:26:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\\\/#primaryimage\",\"url\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Screenshot-2026-07-14-at-11.25.48-AM.png\",\"contentUrl\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Screenshot-2026-07-14-at-11.25.48-AM.png\",\"width\":1498,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/news-events\\\/news-insights\\\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/admarebio.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News & Events\",\"item\":\"https:\\\/\\\/admarebio.com\\\/en\\\/news-events\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News & Insights\",\"item\":\"https:\\\/\\\/admarebio.com\\\/en\\\/news-events\\\/news-insights\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"The Future of BioInnovation: What Canada Must Do Now to Lead\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/admarebio.com\\\/en\\\/\",\"name\":\"adMare\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/admarebio.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#organization\",\"name\":\"adMare\",\"url\":\"https:\\\/\\\/admarebio.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Logo-light.svg\",\"contentUrl\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Logo-light.svg\",\"width\":915,\"height\":337,\"caption\":\"adMare\"},\"image\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#\\\/schema\\\/person\\\/bd78e975574bdbf66541602c00a312da\",\"name\":\"Earnscliffe Strategies\",\"url\":\"#\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Future of BioInnovation: What Canada Must Do Now to Lead | adMare","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"The Future of BioInnovation: What Canada Must Do Now to Lead | adMare","og_description":"Originally published: https:\/\/thefutureeconomy.ca\/op-eds\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\/ Canada is making a series of deliberate choices about its economic and strategic future. We are diversifying trading partners, investing in domestic capacity and strengthening our commitment […]","og_url":"https:\/\/admarebio.com\/news-events\/news-insights\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\/","og_site_name":"adMare","article_published_time":"2026-06-26T18:17:00+00:00","article_modified_time":"2026-07-14T18:26:13+00:00","og_image":[{"width":1498,"height":854,"url":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-07-14-at-11.25.48-AM.png","type":"image\/png"}],"author":"Earnscliffe Strategies","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Earnscliffe Strategies","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/admarebio.com\/news-events\/news-insights\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\/#article","isPartOf":{"@id":"https:\/\/admarebio.com\/news-events\/news-insights\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\/"},"author":{"name":"Earnscliffe Strategies","@id":"https:\/\/admarebio.com\/en\/#\/schema\/person\/bd78e975574bdbf66541602c00a312da"},"headline":"The Future of BioInnovation: What Canada Must Do Now to Lead","datePublished":"2026-06-26T18:17:00+00:00","dateModified":"2026-07-14T18:26:13+00:00","mainEntityOfPage":{"@id":"https:\/\/admarebio.com\/news-events\/news-insights\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\/"},"wordCount":1143,"publisher":{"@id":"https:\/\/admarebio.com\/en\/#organization"},"image":{"@id":"https:\/\/admarebio.com\/news-events\/news-insights\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\/#primaryimage"},"thumbnailUrl":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-07-14-at-11.25.48-AM.png","articleSection":["adMare Insights"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/admarebio.com\/news-events\/news-insights\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\/","url":"https:\/\/admarebio.com\/news-events\/news-insights\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\/","name":"The Future of BioInnovation: What Canada Must Do Now to Lead | adMare","isPartOf":{"@id":"https:\/\/admarebio.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/admarebio.com\/news-events\/news-insights\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\/#primaryimage"},"image":{"@id":"https:\/\/admarebio.com\/news-events\/news-insights\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\/#primaryimage"},"thumbnailUrl":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-07-14-at-11.25.48-AM.png","datePublished":"2026-06-26T18:17:00+00:00","dateModified":"2026-07-14T18:26:13+00:00","breadcrumb":{"@id":"https:\/\/admarebio.com\/news-events\/news-insights\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/admarebio.com\/news-events\/news-insights\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/admarebio.com\/news-events\/news-insights\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\/#primaryimage","url":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-07-14-at-11.25.48-AM.png","contentUrl":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-07-14-at-11.25.48-AM.png","width":1498,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/admarebio.com\/news-events\/news-insights\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/admarebio.com\/en\/"},{"@type":"ListItem","position":2,"name":"News & Events","item":"https:\/\/admarebio.com\/en\/news-events\/"},{"@type":"ListItem","position":3,"name":"News & Insights","item":"https:\/\/admarebio.com\/en\/news-events\/news-insights\/"},{"@type":"ListItem","position":4,"name":"The Future of BioInnovation: What Canada Must Do Now to Lead"}]},{"@type":"WebSite","@id":"https:\/\/admarebio.com\/en\/#website","url":"https:\/\/admarebio.com\/en\/","name":"adMare","description":"","publisher":{"@id":"https:\/\/admarebio.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/admarebio.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/admarebio.com\/en\/#organization","name":"adMare","url":"https:\/\/admarebio.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/admarebio.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/03\/Logo-light.svg","contentUrl":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/03\/Logo-light.svg","width":915,"height":337,"caption":"adMare"},"image":{"@id":"https:\/\/admarebio.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/admarebio.com\/en\/#\/schema\/person\/bd78e975574bdbf66541602c00a312da","name":"Earnscliffe Strategies","url":"#"}]}},"_links":{"self":[{"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/posts\/2409","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/comments?post=2409"}],"version-history":[{"count":2,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/posts\/2409\/revisions"}],"predecessor-version":[{"id":2412,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/posts\/2409\/revisions\/2412"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/media\/2413"}],"wp:attachment":[{"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/media?parent=2409"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/categories?post=2409"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/tags?post=2409"},{"taxonomy":"company","embeddable":true,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/company?post=2409"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}